isabelobrien, Author at European Medical Journal - Page 2 of 29

Hidden heroes of healthcare: Reaching NPs and PAs

Nurse practitioners and physician assistants are vital players in US healthcare, yet the industry often overlooks them.

ViiV, Roche and Gilead lead pharma patient group rankings

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways to improve.

Handshake on blue background

Boehringer and Tessellate partner to tackle tough cancer targets

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies.

5 minutes with... Dr Tami Nussbaum, Takeda

Dr Tami Nussbaum, shares why she left medicine for pharma, the challenges of rare disease and how she avoids burnout.

US pharma tariffs: What they mean for drug prices

US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here’s what pharma leaders need to know.

5 minutes with... Kate Lenik, Chiesi

Kate Lenik shares her journey into HR, the evolving pharma workplace, and the secrets behind Chiesi’s award-winning culture.

Scientists crack the code for keeping lab-grown tissue alive

FluidForm Bio’s 3D bioprinting tech keeps lab-grown cells alive five times deeper using vascular-like gelatin scaffolds.

Lightening bolt on grey background

New tool supercharges lipid nanoparticle analysis

CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and vaccine research.

An illustrated older man and woman cycling on bikes and looking happy and healthy

The clock, the germ and the gut: Pharma’s role in healthy ageing

How pharma could shift from curing disease to promoting healthy ageing through epigenetics, the microbiome and antimicrobial innovation.

Pharma must balance creativity and trust in 2025, says VML

Pharma must balance creativity with transparency to rebuild trust in 2025. VML Health’s report reveals key trends shaping expectations.